| [1] |
ALI M, RAMADAN A, SURANI S. Obstructive sleep apnea-hypopnea syndrome immunological relationship[J]. World J Clin Cases, 2024, 12(27): 6011-6014. DOI: 10.12998/wjcc.v12.i27.6011.
|
| [2] |
SONG R L, BAKER T L, WATTERS J J, et al. Obstructive sleep apnea-associated intermittent hypoxia-induced immune responses in males, pregnancies, and offspring[J]. Int J Mol Sci, 2024, 25(3): 1852. DOI: 10.3390/ijms25031852.
|
| [3] |
|
| [4] |
陈阳, 章小娟, 王菁, 等. 揿针治疗女性辅助生殖患者睡眠障碍与妊娠结局临床研究[J]. 湖北中医药大学学报, 2023, 25(4): 89-91.
|
| [5] |
ZHANG Q F, WANG Z H, DING J L, et al. Effect of obstructive sleep apnea on in vitro fertilization outcomes in women with polycystic ovary syndrome[J]. J Clin Sleep Med, 2024, 20(1): 31-38. DOI: 10.5664/jcsm.10780.
|
| [6] |
HAUFE A, LEENERS B. Sleep disturbances across a woman's lifespan: what is the role of reproductive hormones?[J]. J Endocr Soc, 2023, 7(5): bvad036. DOI: 10.1210/jendso/bvad036.
|
| [7] |
|
| [8] |
LIM Z W, WANG I D, WANG P, et al. Obstructive sleep apnea increases risk of female infertility: a 14-year nationwide population-based study[J]. PLoS One, 2021, 16(12): e0260842. DOI: 10.1371/journal.pone.0260842.
|
| [9] |
李银丹, 郭敏, 侯海燕. 女性性激素水平与睡眠障碍的关系[J]. 发育医学电子杂志, 2024, 12(3): 235-240.
|
| [10] |
宗嬿, 陈宜爽, 徐莲薇. 围绝经期睡眠障碍的发病机制[J]. 国际生殖健康/计划生育杂志, 2024, 43(2): 166-171.
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
缪晨韵, 赵颖, 陈赟, 等. 何氏养巢方通过ERβ/PCG1α/TFAM通路提高颗粒细胞线粒体生物发生以改善早发性卵巢功能不全[J]. 浙江大学学报(医学版), 2024, 53(3): 358-367.
|
| [15] |
GALATI D, ZANOTTA S, CANORA A, et al. Severe depletion of peripheral blood dendritic cell subsets in obstructive sleep apnea patients: a new link with cancer?[J]. Cytokine, 2020, 125: 154831. DOI: 10.1016/j.cyto.2019.154831.
|
| [16] |
|
| [17] |
SUN X, HOSOMI K, SHIMOYAMA A, et al. TLR4 agonist activity of Alcaligenes lipid a utilizes MyD88 and TRIF signaling pathways for efficient antigen presentation and T cell differentiation by dendritic cells[J]. Int Immunopharmacol, 2023, 117: 109852. DOI: 10.1016/j.intimp.2023.109852.
|
| [18] |
SALAZAR F, AWUAH D, NEGM O H, et al. The role of indoleamine 2, 3-dioxygenase-aryl hydrocarbon receptor pathway in the TLR4-induced tolerogenic phenotype in human DCs[J]. Sci Rep, 2017, 7: 43337. DOI: 10.1038/srep43337.
|
| [19] |
|
| [20] |
|